Skip to content

Safety and feasibility of virtual reality-guided rehabilitation for chemotherapy-induced peripheral neuropathy.

Virtual Reality-guided rehabilitation for patients with chemotherapy-induced peripheral neuropathy - VR-guided rehabilitation for CIPN

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000056203
Enrollment
7
Registered
2024-11-19
Start date
2023-03-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chemotherapy-induced peripheral neuropathy

Interventions

None listed

Sponsors

NHO Tokyo Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Individuals who visited the cancer rehabilitation and locomotion outpatient clinic of the institution and underwent VR-guided rehabilitation for chemotherapy-induced peripheral neuropathy.

Exclusion criteria

Exclusion criteria: Individuals who have indicated their intention not to participate in the study.

Design outcomes

Primary

MeasureTime frame
Number of VR-guided rehabilitation sessions and drop-out rates

Secondary

MeasureTime frame
neurological symptoms, physical function (grip strength, balance),participants perspective, adverse events.

Countries

Japan

Contacts

Public ContactChieko Miyata

NHO Tokyo Medical Center Palliative care medicine and Cancer rehabilitation

kuma1mie2chibi3@yahoo.co.jp0334110111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026